Literature DB >> 31846298

Assessing the Cell Permeability of Bivalent Chemical Degraders Using the Chloroalkane Penetration Assay.

Caroline A Foley1, Frances Potjewyd1, Kelsey N Lamb1, Lindsey I James1, Stephen V Frye1.   

Abstract

Bivalent chemical degraders provide a catalytic route to selectively degrade disease-associated proteins. By linking target-specific ligands with E3 ubiquitin ligase recruiting ligands, these compounds facilitate targeted protein ubiquitination and degradation by the proteasome. Due to the complexity of this multistep mechanism, the development of effective degrader molecules remains a difficult, lengthy, and unpredictable process. Since degraders are large heterobifunctional molecules, the efficacy of these compounds may be limited by poor cell permeability, and an efficient and reliable method to quantify the cell permeability of these compounds is lacking. Herein, we demonstrate that by the addition of a chloroalkane tag on the BRD4 specific degrader, MZ1, cell permeability can be quantified via the chloroalkane penetration assay. By extending this analysis to individual components of the degrader molecule, we have obtained structure-permeability relationships that will be informative for future degrader development, particularly as degraders move into the clinic as potential therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31846298      PMCID: PMC7010361          DOI: 10.1021/acschembio.9b00972

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  40 in total

1.  A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader.

Authors:  Hai-Tsang Huang; Dennis Dobrovolsky; Joshiawa Paulk; Guang Yang; Ellen L Weisberg; Zainab M Doctor; Dennis L Buckley; Joong-Heui Cho; Eunhwa Ko; Jaebong Jang; Kun Shi; Hwan Geun Choi; James D Griffin; Ying Li; Steven P Treon; Eric S Fischer; James E Bradner; Li Tan; Nathanael S Gray
Journal:  Cell Chem Biol       Date:  2017-11-09       Impact factor: 8.116

2.  The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study.

Authors:  George M Burslem; Blake E Smith; Ashton C Lai; Saul Jaime-Figueroa; Daniel C McQuaid; Daniel P Bondeson; Momar Toure; Hanqing Dong; Yimin Qian; Jing Wang; Andrew P Crew; John Hines; Craig M Crews
Journal:  Cell Chem Biol       Date:  2017-11-09       Impact factor: 8.116

Review 3.  Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?

Authors:  Ian Churcher
Journal:  J Med Chem       Date:  2017-12-19       Impact factor: 7.446

4.  Cell Penetration Profiling Using the Chloroalkane Penetration Assay.

Authors:  Leila Peraro; Kirsten L Deprey; Matthew K Moser; Zhongju Zou; Haydn L Ball; Beth Levine; Joshua A Kritzer
Journal:  J Am Chem Soc       Date:  2018-08-31       Impact factor: 15.419

5.  Chemical genetic control of protein levels: selective in vivo targeted degradation.

Authors:  John S Schneekloth; Fabiana N Fonseca; Michael Koldobskiy; Amit Mandal; Raymond Deshaies; Kathleen Sakamoto; Craig M Crews
Journal:  J Am Chem Soc       Date:  2004-03-31       Impact factor: 15.419

6.  Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds.

Authors:  Kwok-Ho Chan; Michael Zengerle; Andrea Testa; Alessio Ciulli
Journal:  J Med Chem       Date:  2017-06-22       Impact factor: 7.446

7.  Diversity-Oriented Stapling Yields Intrinsically Cell-Penetrant Inducers of Autophagy.

Authors:  Leila Peraro; Zhongju Zou; Kamlesh M Makwana; Ashleigh E Cummings; Haydn L Ball; Hongtao Yu; Yu-Shan Lin; Beth Levine; Joshua A Kritzer
Journal:  J Am Chem Soc       Date:  2017-05-09       Impact factor: 15.419

8.  Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation.

Authors:  Chiara Maniaci; Scott J Hughes; Andrea Testa; Wenzhang Chen; Douglas J Lamont; Sonia Rocha; Dario R Alessi; Roberto Romeo; Alessio Ciulli
Journal:  Nat Commun       Date:  2017-10-10       Impact factor: 14.919

Review 9.  The PROTAC technology in drug development.

Authors:  Yutian Zou; Danhui Ma; Yinyin Wang
Journal:  Cell Biochem Funct       Date:  2019-01-02       Impact factor: 3.685

10.  Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766).

Authors:  Nicola E A Chessum; Swee Y Sharp; John J Caldwell; A Elisa Pasqua; Birgit Wilding; Giampiero Colombano; Ian Collins; Bugra Ozer; Meirion Richards; Martin Rowlands; Mark Stubbs; Rosemary Burke; P Craig McAndrew; Paul A Clarke; Paul Workman; Matthew D Cheeseman; Keith Jones
Journal:  J Med Chem       Date:  2018-01-05       Impact factor: 7.446

View more
  18 in total

1.  Quantitative measurement of cytosolic penetration using the chloroalkane penetration assay.

Authors:  Kirsten Deprey; Joshua A Kritzer
Journal:  Methods Enzymol       Date:  2020-04-20       Impact factor: 1.600

2.  A kinetic proofreading model for bispecific protein degraders.

Authors:  Derek W Bartlett; Adam M Gilbert
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-10-22       Impact factor: 2.745

3.  A Cell-Based Target Engagement Assay for the Identification of Cereblon E3 Ubiquitin Ligase Ligands and Their Application in HDAC6 Degraders.

Authors:  Ka Yang; Yu Zhao; Xueqing Nie; Hao Wu; Bo Wang; Chelsi M Almodovar-Rivera; Haibo Xie; Weiping Tang
Journal:  Cell Chem Biol       Date:  2020-05-14       Impact factor: 8.116

4.  Enhanced protein degradation by intracellular delivery of pre-fused PROTACs using lipid-like nanoparticles.

Authors:  Jinjin Chen; Min Qiu; Feihe Ma; Liu Yang; Zachary Glass; Qiaobing Xu
Journal:  J Control Release       Date:  2020-11-21       Impact factor: 9.776

5.  Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta.

Authors:  Nan Bai; Sven A Miller; Grigorii V Andrianov; Max Yates; Palani Kirubakaran; John Karanicolas
Journal:  J Chem Inf Model       Date:  2021-02-24       Impact factor: 4.956

Review 6.  Assays and technologies for developing proteolysis targeting chimera degraders.

Authors:  Xingui Liu; Xuan Zhang; Dongwen Lv; Yaxia Yuan; Guangrong Zheng; Daohong Zhou
Journal:  Future Med Chem       Date:  2020-05-20       Impact factor: 3.808

Review 7.  A critical analysis of methods used to investigate the cellular uptake and subcellular localization of RNA therapeutics.

Authors:  Kirsten Deprey; Nefeli Batistatou; Joshua A Kritzer
Journal:  Nucleic Acids Res       Date:  2020-08-20       Impact factor: 16.971

Review 8.  Prey for the Proteasome: Targeted Protein Degradation-A Medicinal Chemist's Perspective.

Authors:  Laura M Luh; Ulrike Scheib; Katrin Juenemann; Lars Wortmann; Michael Brands; Philipp M Cromm
Journal:  Angew Chem Int Ed Engl       Date:  2020-07-30       Impact factor: 15.336

Review 9.  Advancing targeted protein degradation for cancer therapy.

Authors:  Brandon Dale; Meng Cheng; Kwang-Su Park; H Ümit Kaniskan; Yue Xiong; Jian Jin
Journal:  Nat Rev Cancer       Date:  2021-06-15       Impact factor: 60.716

10.  Parallel Screening Using the Chloroalkane Penetration Assay Reveals Structure-Penetration Relationships.

Authors:  Kaley M Mientkiewicz; Leila Peraro; Joshua A Kritzer
Journal:  ACS Chem Biol       Date:  2021-07-05       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.